Literature DB >> 11747338

Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells.

O Berthier-Vergnes1, M Gaucherand, J Péguet-Navarro, J Plouet, J F Pageaux, D Schmitt, M J Staquet.   

Abstract

Tumour-derived factors suppress differentiation and function of in vitro generated DC. Here, we investigate the effect of two melanoma clones differing in their invasive and metastatic properties on the generation and/or functional maturation of human epidermal LC. LC were generated from CD34(+) cord blood progenitors under GM-CSF/TNF-alpha/TGF-beta 1. CD34(+) cells were co-cultured with or without melanoma cells using Transwell dishes. After 11 days of co-culture, CD34(+)-derived cells display a non-adherent undifferentiated morphology, a high level of monocytic CD14 marker, a down-regulated expression of LC markers (CD1a, E-cadherin) and DC markers (CD40, CD80, CD54, CD58, CD83, CD86, HLA-DR, HLA-class I). These cells were less potent than control LC in inducing allogeneic T cell proliferation. The generation of the CD14(+) population was correlated with a decrease in the CD1a(+) population, without any statistical differences between the two clones. Melanoma cells diverted the differentiation of CD34(+) cells towards a dominant CD14(+) population only if the progenitors were in an early growth phase. IL-10, TGF-beta 1 and VEGF were not responsible for these effects, as assessed by using blocking antibodies. By contrast, co-culture of fresh epidermal LC with melanoma cells did not affect their phenotype and function. Our data demonstrate that melanoma cells inhibit the earliest steps of LC differentiation, but failed to affect the functional maturation of epidermal LC. This suggests that melanoma cells participate in their own escape from immunosurveillance by preventing LC generation in the local cutaneous microenvironment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747338      PMCID: PMC2364014          DOI: 10.1054/bjoc.2001.2183

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII.

Authors:  N Bechetoille; M Haftek; M J Staquet; A J Cochran; D Schmitt; O Berthier-Vergnes
Journal:  Melanoma Res       Date:  2000-10       Impact factor: 3.599

2.  Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors.

Authors:  C Caux; C Massacrier; B Dubois; J Valladeau; C Dezutter-Dambuyant; I Durand; D Schmitt; S Saeland
Journal:  J Leukoc Biol       Date:  1999-11       Impact factor: 4.962

3.  Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.

Authors:  G V Shurin; M R Shurin; S Bykovskaia; J Shogan; M T Lotze; E M Barksdale
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

4.  Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts.

Authors:  S Trompezinski; I Pernet; C Mayoux; D Schmitt; J Viac
Journal:  Br J Dermatol       Date:  2000-09       Impact factor: 9.302

5.  Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function.

Authors:  N S Katsenelson; G V Shurin; S N Bykovskaia; J Shogan; M R Shurin
Journal:  Mod Pathol       Date:  2001-01       Impact factor: 7.842

6.  CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner.

Authors:  S Jaksits; E Kriehuber; A S Charbonnier; K Rappersberger; G Stingl; D Maurer
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

7.  Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin.

Authors:  M A Stene; M Babajanians; S Bhuta; A J Cochran
Journal:  J Invest Dermatol       Date:  1988-08       Impact factor: 8.551

8.  Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin.

Authors:  K Toriyama; D R Wen; E Paul; A J Cochran
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

9.  Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.

Authors:  C D Reid; A Stackpoole; A Meager; J Tikerpae
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

10.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

Authors:  C Caux; C Dezutter-Dambuyant; D Schmitt; J Banchereau
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

View more
  6 in total

1.  Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.

Authors:  Hideki Fujita; Mayte Suárez-Fariñas; Hiroshi Mitsui; Juana Gonzalez; Mark J Bluth; Shali Zhang; Diane Felsen; James G Krueger; John A Carucci
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

Review 2.  Immunotherapy for melanoma: the good, the bad, and the future.

Authors:  Christian H Poehlein; Dominik Rüttinger; Jun Ma; Hong-Ming Hu; Walter J Urba; Bernard A Fox
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

Review 3.  Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.

Authors:  Mathias Oelke; Jonathan P Schneck
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

4.  Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma.

Authors:  Jelle J Lindenberg; Rieneke van de Ven; Dinja Oosterhoff; Claudia C Sombroek; Sinéad M Lougheed; Anita G M Stam; Hans J P M Koenen; Alfons J M van den Eertwegh; Rik J Scheper; Tanja D de Gruijl
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

Review 5.  Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.

Authors:  Angelo Aquino; Grazia Graziani; Ornella Franzese; Salvatore P Prete; Enzo Bonmassar; Laura Bonmassar; Stefania D'Atri
Journal:  Clin Dev Immunol       Date:  2011-03-22

6.  Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells.

Authors:  Katrien Pletinckx; Anja Döhler; Vladimir Pavlovic; Manfred B Lutz
Journal:  Front Immunol       Date:  2011-09-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.